Unknown

Dataset Information

0

CYP3A5 phenotype-genotype correlations in a British population.


ABSTRACT: AIMS:To develop a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP)-based assay to genotype for hepatic CYP3A5 expression and to use this assay to study a British population. METHODS:CYP3A5-specific primers were designed with one including a base-pair mismatch to create a RsaI site in samples positive for G6986 (CYP3A5*3 allele) [correction]. Following PCR and RsaI digestion, different band patterns on electrophoresis were predicted for individuals positive for CYP3A5 (CYP3A5*1 allele) compared with those who do not express the gene (CYP3A5*3 homozygotes). The assay was validated by DNA sequencing. DNA samples from a human liver bank consisting of 22 livers whose CYP3A5 expression had been determined by immunoblotting and a group of random individuals (n = 100) from the North-east of England were genotyped by the new assay. RESULTS:In the liver bank, five out of 22 samples expressed CYP3A5 at significant levels (>20 pmol mg-1 protein) and were found to have the genotype CYP3A5*1/CYP3A5*3 by the PCR-RFLP assay. All other liver DNA samples were CYP3A5*3 homozygotes. In the group of 100 random individuals, 13 had the genotype CYP3A5*1/CYP3A5*3 and all others were CYP3A5*3 homozygotes, predicting that 13% (95% confidence interval (CI) 6%, 20%) would show significant hepatic CYP3A5 expression. The frequency for the CYP3A5*1 allele was 0.065 (95% CI 0.032, 0.097). CONCLUSIONS:We have developed a simple assay for the detection of the CYP3A5*1/CYP3A5*3 alleles and shown that in a British population their frequency is similar to that reported previously. We have also shown a good correlation between hepatic CYP3A5 expression and genotype for a British Caucasian liver bank.

SUBMITTER: King BP 

PROVIDER: S-EPMC1884247 | biostudies-literature | 2003 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

CYP3A5 phenotype-genotype correlations in a British population.

King Barry P BP   Leathart Julian B S JB   Mutch Elaine E   Williams Faith M FM   Daly Ann K AK  

British journal of clinical pharmacology 20030601 6


<h4>Aims</h4>To develop a polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP)-based assay to genotype for hepatic CYP3A5 expression and to use this assay to study a British population.<h4>Methods</h4>CYP3A5-specific primers were designed with one including a base-pair mismatch to create a RsaI site in samples positive for G6986 (CYP3A5*3 allele) [correction]. Following PCR and RsaI digestion, different band patterns on electrophoresis were predicted for individuals po  ...[more]

Similar Datasets

| S-EPMC6416831 | biostudies-literature
| S-EPMC1156885 | biostudies-literature
| S-EPMC2928780 | biostudies-other
| S-EPMC8304328 | biostudies-literature
| S-EPMC1377162 | biostudies-other
2018-11-06 | GSE89594 | GEO
| S-EPMC7565052 | biostudies-literature
| S-EPMC6217001 | biostudies-literature
| S-EPMC4795106 | biostudies-literature
| S-EPMC1216057 | biostudies-literature